4.8 Article

A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis

期刊

NATURE COMMUNICATIONS
卷 9, 期 -, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41467-018-03278-w

关键词

-

资金

  1. Canadian Institute of Health Research (CIHR) [119325, 148629]
  2. Canadian Breast Cancer Foundation (CBCF)
  3. Roswell Park Cancer Institute
  4. National Cancer Institute (NCI) [P30 CA016056, R01 CA207504]
  5. Roswell Park Alliance Foundation
  6. American Cancer Society Research Scholar [RSG-14-214-01-TBE]
  7. Vanier Canada Graduate Scholarship
  8. Ontario International Graduate Scholarship
  9. Queen Elizabeth II Graduate Scholarship in Science and Technology
  10. NATIONAL CANCER INSTITUTE [R35CA196878, R21CA179693, P30CA016056, R01CA207504] Funding Source: NIH RePORTER

向作者/读者索取更多资源

The Hippo pathway is a central regulator of tissue development and homeostasis, and has been reported to have a role during vascular development. Here we develop a bioluminescence-based biosensor that monitors the activity of the Hippo core component LATS kinase. Using this biosensor and a library of small molecule kinase inhibitors, we perform a screen for kinases modulating LATS activity and identify VEGFR as an upstream regulator of the Hippo pathway. We find that VEGFR activation by VEGF triggers PI3K/MAPK signaling, which subsequently inhibits LATS and activates the Hippo effectors YAP and TAZ. We further show that the Hippo pathway is a critical mediator of VEGF-induced angiogenesis and tumor vasculogenic mimicry. Thus, our work offers a biosensor tool for the study of the Hippo pathway and suggests a role for Hippo signaling in regulating blood vessel formation in physiological and pathological settings.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据